purpleDx Pulmonary Disease Smartphone App Set for Release
electronRx announced it will launch purpleDx, a smartphone app for cardiopulmonary assessment, at CES 2025.
electronRx announced it will launch purpleDx, a smartphone app for cardiopulmonary assessment, at CES 2025.
ADLM's new guidance on clinical testing for respiratory viral infections emphasizes the use of advanced diagnostic methods and sample types.
Sekisui Diagnostics' OSOM Ultra Plus Flu A&B Test is a rapid antigen test that takes only 10 minutes at the point of care.
Visby Medical has received Emergency Use Authorization (EUA) from the U.S. FDA for its Respiratory Health point of care test.
Read MoreTwo out of three Americans are confused by the differences between polymerase chain reaction, or PCR, tests, and rapid antigen tests.
Read MoreSameday Health launched a single swab test for COVID, influenza A/B strains, and respiratory syncytial virus (RSV).
Read MoreThe Spanish flu, which ravaged the world 100 years ago, is largely forgotten today. Will the same thing happen with the COVID-19 pandemic?
Read MoreCurrently circulating mutant strain variants of influenza are detectable through Cepheid’s respiratory tests.
Read MoreJin Yong Jeon of Hanyang University discussed a technique using a machine learning algorithm to diagnose pneumonia through passive listening.
Read MoreSyndromic testing provides labs flexibility, maximizes equipment and personnel resources, and helps control costs.
Read MoreThe cost of returning to normal activities may not only be a spike in COVID and the more common coronavirus the “common” cold, but influenza. Testing for both coronaviruses and influenza should be standard operating procedure at the first sign of symptoms.
Read MoreResearchers have discovered a high prevalence of COVID co-infections in central Missouri during the 2021-2022 flu season.
Read MoreResearchers used nose swabs from children with RSV in the PICU within a few days of hospital stay to examine what genes respond to the virus.
Read MoreCue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Read MoreScientists created a face mask that detects common respiratory viruses, like influenza and COVID, in the air in droplets or aerosols.
Read MoreA new report that detailed how RDTs for influenza used by individuals at home could potentially expand access to testing.
Read MorePreliminary clinical study results for Lucira’s COVID-19 & Flu test demonstrated similar sensitivity and specificity to lab-based PCR assays.
Read MoreVisby Medical received $25.5 million in federal funding to develop and validate an at-home combination Flu-Covid test from BARDA.
Read More